Scrolling news:

Palestine: Gaza casualty toll on the rise, Israeli strikes continue on day 20

Palestine: Eight Palestinians killed, dozens wounded Sunday

Eid moon sighting possiblities, Muslims in South Africa have declared Eid

Pakistan: More rain with thunder, lightening forecast in next 24 hours in Rawalpindi

Libya: US embassy evacuated after heavy violence

Palestine: List of Palestinians killed by Israeli forces between July 8 to July 27

Palestine: Two Palestinians beaten by Jewish mob in Jerusalem

Palestine: Reports show murder of 3 Israeli teenage settlers was not carried out by Hamas

Palestine: Remains of 85 Palestinians located under rubble of bombarded homes

Palestine: Ten Palestinians killed by Israeli forces in West Bank

Palestine: At least 15 kidnapped by Israeli forces from West Bank

Palestine: Palestinians pull over 140 bodies from under Gaza rubble, total killed 1000

Lebanon: Nasrallah: Israel on a path towards “suicide” in Gaza

Palestine: Two Palestinians killed as tens of thousands protest Israeli assault across West Bank

Palestine: Amid Gaza ceasefire calm, at least 40 dead bodies are found

Palestine: Entire 20 members of one family in Gaza killed prior to ceasefire, as death toll tops 940

Palestine: Seventeen killed in early morning hours of Friday

Palestine: Israeli forces invade Azzun in W Bank, use Palestinian civilians as human shields

Palestine: 931 Palestinians from Jerusalem & inside Israel taken captive in 3 Weeks

Saudi Arabia behind effort to disarm the Palestinian Resistance

US: Firms cannot patent human genes, US court rules

14th Jun 2013

The US Supreme Court has ruled against patents for extracted human DNA, though synthesized genetic strains remain eligible. The court ruled that isolating naturally occurring material did not satisfy patent requirements.

In a unanimous vote on Thursday, the US Supreme Court in Washington ruled that human DNA came from nature and was therefore not eligible for patenting.

“A naturally occurring DNA segment is a product of nature and not patent-eligible merely because it has been isolated,” the court stated.

The nine justices struck down patents held by Myriad Genetics on two genes – BCRA1 and BCRA2 – linked to increased risk of breast and ovarian cancer. Having isolated, but in no way altered, the genes, Myriad Genetics had applied for exclusive rights to the strands – winning the case in lower courts.

In the previous cases, now overturned, judges had said that the isolated DNA had a “markedly different chemical structure” from that found in healthy bodies.

Thursday’s ruling pleased opponents who had been saying all along that patent protection shouldn’t be given to something that can be found inside the human body.

The US Supreme Court offered a compromise ruling in so far as reasoning that synthetically produced genetic material, also known as cDNA could after all be patented, because it was not naturally occurring and hence merited full legal protection.

“cDNA is patent-eligible because it is not naturally occurring,” the Supreme Court ruling said, going on to say that Myriad’s isolation of particular genes did not satisfy a requirement to claim a “new and useful … composition of matter” needed to secure a patent. “Myriad did not create or alter either the information encoded in the BCRA1 and BCRA2 genes or the genetic structure of the DNA. It found an important and useful gene, but groundbreaking, innovative, or even brilliant discovery does not by itself satisfy the… inquiry.”

hg/msh (Reuters, AP, AFP)


Comments are closed.

Sectarianism in the Middle East and its rise in the UK, Standpoint, Sahar TV. Interview 29 May 2013 and aired on 12 June 2013

Latest Tweets

The Muslim News


Awards for Excellence

Read more